Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Kramer Levin Naftalis & Frankel LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Delaware Supreme Court Allows Caremark Breach Of Loyalty Claim To Go Forward
On June 18, in Marchand v. Barnhill, the Delaware Supreme Court reversed a ruling by the Delaware Court of Chancery in a shareholder derivative suit alleging a breach of the duty of loyalty.
United States
29 Jul 2019
2
Development Of Substituted Pyrido[3,2-D]Pyrimidines As Potent And Selective Dihydrofolate Reductase Inhibitors For Pneumocystis Pneumonia Infection
Intellectual Property scientific advisor Khushbu Shah co-authored an article titled "Development of Substituted Pyrido[3,2-d]Pyrimidines as Potent and Selective Dihydrofolate Reductase
United States
29 Jul 2019
3
Novel Pyrrolo[3,2-D]Pyrimidine Compounds Target Mitochondrial And Cytosolic One-Carbon Metabolism With Broad-Spectrum Antitumor Efficacy
Intellectual Property scientific advisor Khushbu Shah co-authored an article titled "Novel Pyrrolo[3,2-d]Pyrimidine Compounds Target Mitochondrial and Cytosolic One-Carbon Metabolism
United States
26 Jul 2019
4
NYC Employers Can No Longer Use Pre-Employment Marijuana Testing To Weed Out Prospective Employees
On April 9, 2019, the New York City Council passed a bill that prohibits employers from conducting pre-employment drug testing for the presence of marijuana or tetrahydrocannabinols (THC).
United States
20 May 2019
5
Catalyst, BNP Paribas Partner On Risk Premia Index, Launch Liquid Alternative Fund
Liquid alternative mutual fund specialist Catalyst Funds and BNP Paribas partnered to form the BNP Paribas Catalyst Systematic Alpha Index, a risk premia strategy that allocates between seven strategies ...
United States
18 Jan 2018
6
Debtwire: Kramer Levin's Adam Rogoff Breaks Down Decisions In Momentive Performance And Millennium Health
Corporate Restructuring and Bankruptcy partner Adam C. Rogoff joined Debtwire's Richard Goldman for a podcast discussion on the makewhole premium and replacement note interest rate...
United States
4 Dec 2017
7
Supreme Court Issues Highly Anticipated Decision Interpreting The Biologics Price Competition And Innovation Act
On June 12, the Supreme Court decided Sandoz Inc. v. Amgen Inc., the first case under the Biologics Price Competition and Innovation Act of 2009 (BPCIA) to reach the high court.
United States
4 Jul 2017
8
Code Red: Healthcare Restructurings On The Rise
"Code Red: Healthcare Restructurings on the Rise," by Corporate Restructuring and Bankruptcy partner Adam C. Rogoff, special counsel Anupama Yerramalli and associate Priya K. Baranpuria...
United States
9 Jun 2017
9
Supreme Court To Consider Biologics Price Competition And Innovation Act
This alert examines the Supreme Court's granting of the appellant's petition and the respondent's cross-petition for a writ of certiorari in Sandoz Inc. v. Amgen Inc.
United States
19 Jan 2017
10
The More Things Change In Marijuana Investment Law, The More Things Stay The Same
Voters in eight states legalized marijuana on November 8: recreational marijuana in California, Maine, Massachusetts and Nevada and medical marijuana in Arkansas, Florida, Montana and North Dakota.
United States
8 Dec 2016
11
FDA Declares Label "Evaporated Cane Juice" False And Misleading In New Guidance
In its long-awaited final guidance issued May 25, the Food and Drug Administration (FDA) advised against the use of the term "evaporated cane juice" on food labeling, recommending that the ingredient be listed as "sugar" instead.
United States
17 Aug 2016
12
Food Certification Organization's Email To Grocery Stores Enjoined As Commercial Speech
Plaintiff is a farm selling eggs produced by it and others, some of which are packed in Illinois at a facility called Phil's Fresh Eggs. Defendant, HFAC, is a food certification organization.
United States
11 Aug 2016
13
Second Circuit Adopts False Advertising Safe Harbor For Statements Made On FDA-Approved Labeling
In a dispute between rival pharmaceutical manufacturers, the Second Circuit affirmed summary judgment for defendant Acorda Therapeutics, adopting the rule that "representations commensurate with information in an FDA label...
United States
11 Aug 2016
14
Supreme Court Denies Certiorari In Sequenom v. Ariosa
The Supreme Court denies certiorari in Sequenom v. Ariosa, leaving undisturbed the invalidation of a genetic testing patent under Section 101.
United States
29 Jun 2016
15
Recent Legal Developments Demonstrate Increasing Accommodation Of State Marijuana Regimes
Two recent federal court cases will have an effect on the U.S. marijuana industry. One case focused on the validity of the Colorado regime legalizing the sale of marijuana, while the other focused on insurance for a marijuana business.
United States
12 May 2016
16
Federal Circuit Preserves Plaintiff's Choice Of Forum In Hatch-Waxman Cases
On March 18, 2016, the Federal Circuit decided Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc. and held that future sales by a generic defendant of the patented product at issue is a basis for specific jurisdiction over the defendant.
United States
13 Apr 2016
17
Investments In The Marijuana Industry Hold Potential For Significant Growth, Despite Some Uncertainty
Marijuana remains illegal under federal law, and while Congress and the executive branch have not legalized marijuana or rescheduled it from Schedule 1, they have taken steps to divert resources away from prosecution.
United States
10 Mar 2016
Links to Result pages
 
1